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SUMMARY
An altered metal and electrolyte profile has been implicated in the pathologic mecha-
nisms of chronic epilepsy; however, no study has comprehensively measured hippo-
campal concentrations of these elements in patients with mesial temporal lobe
epilepsy and hippocampal sclerosis (mTLE-HS).We therefore analyzed hippocampi of
24 patients with drug-resistantmTLE-HS (mean age 35.6  9.4 years) who underwent
anterior temporal lobe resection and amygdalohippocampectomy and 17 hippocampi
obtained by autopsy from 13 controls (mean age 40.5  12.9 years), using inductively
coupled plasma optical emission spectrometry (ICP-OES). Epileptic hippocampi
showed significantly lower concentrations (lg/g of tissue) of copper (HS: 2.34  0.12;
control [C]: 3.57  0.33; p < 0.001), manganese (HS: 0.205  0.030; C: 0.409  0.064;
p = 0.004), and potassium (HS: 2,001  59; C: 2,322  61; p < 0.001), and increased
sodium levels (HS: 1,131  22; C: 1,040  25; p = 0.010). Zinc, iron, calcium, andmag-
nesium levels did not differ in HS and controls. In summary, copper and manganese
levels are deficient, whereas iron level is unchanged in hippocampi from patients with
mTLE-HS. Our results provide a basis for understanding the potential involvement of
differentmetals and electrolytes in the pathology of HS.
KEYWORDS: Mesial temporal epilepsy, Hippocampal sclerosis, Copper, Manganese,
Electrolytes.
Mesial temporal lobe epilepsy (mTLE) associated with
hippocampal sclerosis (HS) is probably the single most fre-
quent human focal epilepsy and the one most assiduously
investigated. A number of animal and in vitro studies and
some clinical data imply an important role of metals in
mTLE-HS pathophysiology, but the levels of metals and
electrolytes in epileptic human hippocampi have never been
extensively analyzed. Altered levels of zinc and manganese
in the hippocampus have been implicated in seizure devel-
opment.1–3 Copper deficiency in the brain is proposed to
play an essential role in the development of seizures in some
genetic disorders.4 HS represents a common feature of
epilepsy and neurodegenerative conditions, such as
Alzheimer’s disease (AD). It has been recognized that epi-
lepsy- and neurodegeneration-related HS differ in their cel-
lular features.5 However, it is not known whether HS in
epilepsy is accompanied by iron accumulation, which is
found in AD hippocampi.6 Finally, the level of primary
electrolytes (sodium, potassium, calcium, and magnesium)
could be affected by seizures or by changes in structure and
cellular population of sclerotic hippocampus.
In the present study we have examined metal and electro-
lyte profile of sclerotic hippocampi of patients with
drug-resistant mTLE-HS, using inductively coupled plasma
optical emission spectrometry (ICP-OES). Epileptic
hippocampal concentrations of metals and electrolytes were
compared with the profile of control hippocampi.
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Methods
We analyzed hippocampi of 24 patients with drug-resis-
tant (≥2 antiepileptic drug failures) mTLE-HS (mean age
35.6  9.4 years; range 18–56 years; mean duration of epi-
lepsy 22.5  12.8 years; 12 with left HS; m/f = 12/12). In
all patients, MRI findings were consistent with HS, which
was confirmed by histopathologic analysis and classified
according to International League Against Epilepsy (ILAE)
classification of HS in patients with temporal lobe epilepsy
(for further clinical and histologic details see Table S1).7
All patients were rendered “seizure free” following surgery
(median follow-up 25 months). Control hippocampi
(n = 17) were acquired from 13 cadavers (mean age
40.5  12.9 years; range 24–62; nine left hippocampi; m/
f = 8/5), that were limited to sudden death without medical
intervention, prolonged agonal periods, and secondary diag-
nosis of drug/alcohol dependency. Iatrogenic metal intake
was negligible in both groups, that is, no micronutrient sup-
plements, chelating agents, MRI contrasts, or metal-con-
taining pharmaceuticals were prescribed/applied within the
2-year period before sample collection. The research was
performed in accordance with the Declaration of Helsinki of
the World Medical Association and has been approved by
the Clinical Center of Serbia Ethics Committee on Human
Research. Written informed consent was obtained from
every subject or family member.
The epileptic hippocampi were removed en bloc, in the
course of anterior temporal lobe resection and amygdalohip-
pocampectomy. Control hippocampi were removed en bloc
during the autopsy, maximally 10 h following death. The
postmortem specimens were free from brain injury.
Posterior parts of the head of both sclerotic and cadaveric
hippocampi were immediately immersed in liquid nitrogen
and stored at80°C. Prior to preparation of the coronal hip-
pocampal slices, which was conducted in 20°C chamber,
choroidal plexi and/or parts of parahippocampal gyri (subic-
ulum) were removed if present. For the purpose of metal
and electrolyte analysis, coronal hippocampal slices
(200 mg of wet tissue) were digested using ultra-pure
HNO3 (Sigma-Aldrich, St. Louis, MO, U.S.A.), H2O2
(Carlo Erba Reagents, Milano, Italy), and deionized 18 MΩ
water, as described previously.8 Upon digestion, the con-
centrations of Na, K, Ca, Mg, Fe, Cu, Mn, Zn, P, and S were
determined by ICP-OES (SpectroGenesis EOP II; Spectro
Analytical Instruments GmbH, Kleve, Germany).
Results
The profile of metals and electrolytes in hippocampi of
patients with mTLE-HS differed considerably from the con-
trol hippocampal profile (Table 1). The increased level of
sodium and lower concentrations of potassium, copper, and
manganese are evident. Similar trends were observed when
data for left and right hippocampi were processed
separately, although in some cases (Na and K in right hippo-
campi) there was no significant difference between mTLE-
HS and controls. This could be explained by the lower
number of samples per group, or it might result from base-
line characteristics of normal right hippocampus, which
showed slightly lower Na and K concentrations compared
to control left hippocampi. Concentrations of iron, calcium,
and magnesium in HS were next to identical as in control
hippocampi. The level of zinc in sclerotic hippocampi was
increased compared to controls but no statistical signifi-
cance was found. ICP-OES analysis provided the concentra-
tions of two nonmetal macro elements: P and S. Phosphorus
concentration was almost identical in two groups:
3,181  470 in controls, and 3,126  523 lg/g of tissue in
HS. The concentration of sulfur was higher in HS
(2,587  294 lg/g) compared to control values
(2,361  516 lg/g; p = 0.007). Similar results were
obtained separately for left (2,524  347 vs. 2,359  691;
nonsignificant, p = 0.08) and right (2,652  227 vs.
2,363  253; p = 0.025) hippocampi. Spearman’s rank
correlation coefficients (rs) were calculated to determine
dependency between concentrations of investigated ele-
ments. Significant correlations were found for the following
pairs: Ca–Mg (rs = 0.668, p = 0.005), Mg–Mn (rs = 0.509,
p = 0.044), Na–Fe (rs = 0.603, p = 0.004), K–Mg
(rs = 0.606, p = 0.013), K–Mn (rs = 0.762, p < 0.001),
K–P (rs = 0.583, p = 0.014), Mg–P (rs = 0.505,
p = 0.039), and P–S (rs = 0.814, p < 0.001) in control hip-
pocampi; and Ca–Mg (rs = 0.450, p = 0.047), Mn–Zn
(rs = 0.662, p = 0.002), Cu–P (rs = 0.411, p = 0.046), and
P–S (rs = 0.809, p < 0.001) in epileptic hippocampi.
Discussion
Presented values for hippocampal metal and electrolyte
profile are in accordance with previous results on metal con-
centrations in some other brain regions.9 Of note, the age,
which represents a factor that affects brain metal profile
(e.g., the level of iron increases with age),6 was not signifi-
cantly different in two groups. Our results appear to be in
generally good agreement with available data and concepts
in epilepsy research.
HS is characterized by lower neuron counts, which is usu-
ally compensated by gliosis, granule cell dispersion, mossy
fiber sprouting, and neurogenesis.5 However, it appears that
atrophy prevails over tissue remodeling. Increased concen-
tration of sodium (the key extracellular electrolyte) and the
fall in the level of potassium (the main intracellular electro-
lyte) imply that the number of cells or at least intracellular/
extracellular volume ratio is decreased in HS.
Hippocampal tissue in drug-resistant mTLE-HS showed
copper deficiency. This could be placed into the context of
some previous findings: (1) Copper is a cofactor of a num-
ber of metalloenzymes (dopamine b-hydroxylase, Cu-Zn
superoxide dismutase [SOD], cytochrome c oxidase). It is
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important to note that dopamine b-hydroxylase knockouts
generally fail to respond to valproate;10 (2) copper is
released into synaptic cleft after neuronal depolarization
and plays a physiologic role in activity-dependent modula-
tion of synaptic activity. Furthermore, a decrease of copper
concentration promotes N-methyl-D-aspartate (NMDA)
receptor excitotoxicity in hippocampal neurons.4 In relation
to this, copper deficiency in the brain is proposed to play an
essential role in the development of seizures and neuron loss
in Menkes disease, an inherited disorder of copper trans-
port.4 (3) It has been shown that exogenously applied copper
can reduce/inhibit NMDA-mediated potentials/currents in
hippocampal neurons.4
Iron is not accumulated in sclerotic hippocampi of
patients with mTLE, which is in contrast to neurodegenera-
tive settings.6 Hence, prooxidative/cytotoxic activity of iron
is unlikely to be involved in epileptic HS. Our finding is in
accordance with previous notions that hippocampal atrophy
in epilepsy is substantially different compared to neurode-
generative diseases. This could be related to regenerative
capacities of hippocampus that are employed in epilepsy
and involve mossy fiber sprouting, granule cell dispersion,
and neurogenesis,5 but which are absent or compromised in
neurodegenerative conditions.11
Low manganese concentration in human HS that was
observed here might explain severely decreased expression
of hippocampal glutamine synthetase in mTLE that has
been reported previously.12 Glutamine synthetase is the
main manganese metalloprotein in the brain (predominately
located in astrocytes), and its suppression leads to recurrent
seizures.12 It has been reported that brain manganese level
is decreased in model animals after exposure to seizure-
inducing stimuli.2 It is tempting to speculate that a feedback
loop might be present develop between the induction of sei-
zures, manganese level, and glutamine synthetase activity.
In addition, low hippocampal manganese level in HS might
reflect the loss of neurons, which are rich in mitochondrial
antioxidative enzyme–manganese SOD.
In close, low manganese level in HS is likely to represent
the net outcome of a number of pathologic and pathophysio-
logic events.
Zinc is the most intensively investigated metal in epilepsy
research. Studies on animal models of seizures and epilepsy
have found a decrease of hippocampal zinc, as well as alle-
viating/promoting effects of zinc loading/deficiency,
respectively, on susceptibility to seizures.3 However, data
presented here show clearly that the total level of zinc is not
decreased in human epileptogenic hippocampi. Neverthe-
less, a previously proposed concept on the essential role of
zinc distribution (and not concentration per se)1 has gained
a lot of attention. Histologic studies on models and human
samples have documented that zinc accumulation or deple-
tion develops in specific hippocampal cells and regions.3 A
complex role of zinc in synaptic vesicles, extracellular com-
partment, and intracellular stores is also under investiga-
tion.13,14 Therefore, further investigation of specific
localization of zinc in epileptic hippocampi (for example, in
the regions showing mossy fiber sprouting) are needed.
Correlation analysis revealed a general breakdown of
metal and electrolyte homeostasis in epileptic hippocampi.
All correlations between the concentrations of specific met-
als that are found in control hippocampi (where positive cor-
relation between magnesium and manganese levels
represents a general feature of brain tissue9) are lost in HS,
except for Ca–Mg and P–S. On the other hand, HS is charac-
terized by positive correlation between the levels of zinc
Table 1. Hippocampalmetals and electrolytes in patients withmTLE-HS and controls
Metals (lg/g of tissue)
Hippocampi Left hippocampi Right hippocampi
Controls (n = 17) HS (n = 24) Controls (n = 9) HS (n = 12) Controls (n = 8) HS (n = 12)
Na 1,040  25 1,131  22 1,076  32 1,152  28 999  35 1,111  34
p = 0.010 p = 0.049 n.s. (p = 0.09)
K 2,322  61 2,001  59 2,370  103 1,960  70 2,267  58 2,041  97
p < 0.001 p = 0.004 n.s. (p = 0.08)
Ca 104.6  14.1 101.0  14.6 105.2  16.2 108.6  20.8 110.6  23.7 94.6  21.1
n.s. n.s. n.s.
Mg 118.2  4.4 106.8  3.5 117.4  6.5 102.9  6.6 119.2  6.5 110.8  2.1
n.s. n.s. n.s.
Zn 10.97  1.03 13.97  1.51 11.74  1.74 15.35  3.25 10.00  0.84 13.05  1.39
n.s. n.s. n.s.
Fe 61.9  10.7 62.2  5.1 72.4  17.4 63.0  7.7 50.1  11.4 61.4  7.1
n.s. n.s. n.s.
Cu 3.57  0.33 2.34  0.12 3.47  0.51 2.06  0.14 3.68  0.43 2.62  0.17
p < 0.001 p = 0.003 p = 0.025
Mn 0.409  0.064 0.205  0.030 0.429  0.085 0.220  0.052 0.386  0.093 0.190  0.030
p = 0.004 p = 0.016 p = 0.048
All values are given as means  standard error (SE).
Statistical analyses were conducted using STATISTICA 8.0 (StatSoft Inc., Tulsa, OK, U.S.A.). p-Values were determined using nonparametric two-tailed Mann-
Whitney U test. Results were taken to be statistically different if p < 0.05; n.s., nonsignificant.
Epilepsia, 55(5):e34–e37, 2014
doi: 10.1111/epi.12593
e36
A. J. Ristic et al.
and manganese, which implies that a common pathologic
factor might affect the concentrations of these two metals in
HS.
In addition to metal and electrolyte profile, ICP-OES
analysis showed that the concentration of sulfur is increased
in HS compared to control tissue. This could represent an
epiphenomenon of antiepileptic drug–related accumulation
of homocysteine.15 A strong positive correlation between
hippocampal levels of phosphorus and sulfur that was
observed in both control and sclerotic hippocampi, might be
of importance for general (neuro)physiology.
The lack of data from the crime scene, that is, hippocam-
pus, has been one of the drawbacks for understanding the
role of metals in the pathologic mechanisms of mTLE-HS.
Our results fill the gap and provide a relevant prerequisite
for further research of the potential involvement of different
metals in the pathology of HS. It should be noted that this is
the first report on metal and electrolyte profile in HS.
Hence, although our findings might have an impact on
future medication (e.g., copper and manganese replacement
therapy), further confirmation is mandatory in order to draw
major conclusions.
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